CYP19A1 and breast cancer: Similarly, a previous investigation conducted in 2014 by Boone and colleagues showed an inverse correlation between CYP19A1 rs4646 polymorphism and BC risk; however, after multiple comparison adjustments, no statistical significance was reached [54].